Harmony Biosciences (HRMY) Competitors $32.97 -0.36 (-1.08%) Closing price 04:00 PM EasternExtended Trading$33.02 +0.05 (+0.14%) As of 07:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock HRMY vs. ROIV, RVMD, VRNA, BBIO, ELAN, GRFS, TLX, TGTX, NUVL, and LEGNShould you be buying Harmony Biosciences stock or one of its competitors? The main competitors of Harmony Biosciences include Roivant Sciences (ROIV), Revolution Medicines (RVMD), Verona Pharma (VRNA), BridgeBio Pharma (BBIO), Elanco Animal Health (ELAN), Grifols (GRFS), Telix Pharmaceuticals Limited American Depositary Shares (TLX), TG Therapeutics (TGTX), Nuvalent (NUVL), and Legend Biotech (LEGN). These companies are all part of the "pharmaceutical products" industry. Harmony Biosciences vs. Its Competitors Roivant Sciences Revolution Medicines Verona Pharma BridgeBio Pharma Elanco Animal Health Grifols Telix Pharmaceuticals Limited American Depositary Shares TG Therapeutics Nuvalent Legend Biotech Roivant Sciences (NASDAQ:ROIV) and Harmony Biosciences (NASDAQ:HRMY) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, valuation, dividends, institutional ownership, media sentiment, profitability, risk and community ranking. Is ROIV or HRMY more profitable? Harmony Biosciences has a net margin of 17.98% compared to Roivant Sciences' net margin of -119.54%. Harmony Biosciences' return on equity of 23.16% beat Roivant Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Roivant Sciences-119.54% -14.05% -12.81% Harmony Biosciences 17.98%23.16%14.24% Does the media refer more to ROIV or HRMY? In the previous week, Harmony Biosciences had 7 more articles in the media than Roivant Sciences. MarketBeat recorded 13 mentions for Harmony Biosciences and 6 mentions for Roivant Sciences. Harmony Biosciences' average media sentiment score of 1.26 beat Roivant Sciences' score of 0.44 indicating that Harmony Biosciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Roivant Sciences 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Harmony Biosciences 6 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community favor ROIV or HRMY? Harmony Biosciences received 15 more outperform votes than Roivant Sciences when rated by MarketBeat users. However, 78.87% of users gave Roivant Sciences an outperform vote while only 72.45% of users gave Harmony Biosciences an outperform vote. CompanyUnderperformOutperformRoivant SciencesOutperform Votes5678.87% Underperform Votes1521.13% Harmony BiosciencesOutperform Votes7172.45% Underperform Votes2727.55% Which has more risk and volatility, ROIV or HRMY? Roivant Sciences has a beta of 1.16, meaning that its share price is 16% more volatile than the S&P 500. Comparatively, Harmony Biosciences has a beta of 0.87, meaning that its share price is 13% less volatile than the S&P 500. Do analysts prefer ROIV or HRMY? Roivant Sciences presently has a consensus price target of $17.50, indicating a potential upside of 54.59%. Harmony Biosciences has a consensus price target of $53.00, indicating a potential upside of 60.75%. Given Harmony Biosciences' stronger consensus rating and higher probable upside, analysts plainly believe Harmony Biosciences is more favorable than Roivant Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Roivant Sciences 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.00Harmony Biosciences 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 3.11 Do insiders and institutionals believe in ROIV or HRMY? 64.8% of Roivant Sciences shares are owned by institutional investors. Comparatively, 86.2% of Harmony Biosciences shares are owned by institutional investors. 7.9% of Roivant Sciences shares are owned by company insiders. Comparatively, 23.6% of Harmony Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has stronger earnings & valuation, ROIV or HRMY? Roivant Sciences has higher earnings, but lower revenue than Harmony Biosciences. Roivant Sciences is trading at a lower price-to-earnings ratio than Harmony Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRoivant Sciences$29.05M264.87$4.35B-$0.25-45.28Harmony Biosciences$744.85M2.54$128.85M$2.6212.58 SummaryHarmony Biosciences beats Roivant Sciences on 14 of the 18 factors compared between the two stocks. Get Harmony Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for HRMY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HRMY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HRMY vs. The Competition Export to ExcelMetricHarmony BiosciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.89B$6.85B$5.56B$8.50BDividend YieldN/A2.53%5.28%4.16%P/E Ratio15.638.4326.6419.64Price / Sales2.54262.52407.99152.17Price / Cash13.3865.8538.2534.64Price / Book4.146.536.974.60Net Income$128.85M$143.25M$3.23B$248.06M7 Day Performance-7.39%0.21%-0.98%-1.03%1 Month Performance-4.07%10.92%7.70%3.50%1 Year Performance10.79%2.44%31.32%12.68% Harmony Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HRMYHarmony Biosciences4.7667 of 5 stars$32.97-1.1%$53.00+60.8%+13.2%$1.89B$744.85M15.63200Positive NewsShort Interest ↑Analyst RevisionROIVRoivant Sciences2.3485 of 5 stars$11.17+1.6%$17.50+56.7%+5.9%$7.97B$29.05M-74.46860RVMDRevolution Medicines4.4239 of 5 stars$40.65+3.2%$67.08+65.0%+2.8%$7.57B$742K-11.32250Positive NewsVRNAVerona Pharma2.1246 of 5 stars$84.10+3.6%$82.13-2.3%+527.1%$6.82B$118.54M-43.8030Trending NewsAnalyst ForecastInsider TradeAnalyst RevisionBBIOBridgeBio Pharma4.5435 of 5 stars$35.46+3.5%$57.09+61.0%+38.2%$6.73B$127.42M-12.44400Insider TradeAnalyst RevisionELANElanco Animal Health1.0374 of 5 stars$13.440.0%$15.17+12.9%-20.6%$6.67B$4.43B33.599,800Gap DownGRFSGrifols3.7862 of 5 stars$8.30-0.1%N/A+27.7%$5.71B$7.21B7.0926,300TLXTelix Pharmaceuticals Limited American Depositary SharesN/A$16.80-1.1%$22.00+31.0%N/A$5.68B$783.21M0.00N/ANews CoveragePositive NewsAnalyst ForecastTGTXTG Therapeutics3.5225 of 5 stars$35.75+1.8%$40.80+14.1%+122.3%$5.68B$386.39M-357.46290Positive NewsAnalyst RevisionGap DownNUVLNuvalent2.5256 of 5 stars$77.18+3.4%$115.50+49.7%-2.6%$5.54BN/A-22.2440Positive NewsLEGNLegend Biotech3.048 of 5 stars$29.32+1.3%$76.20+159.9%-17.1%$5.39B$728.30M-30.861,070Short Interest ↑Analyst RevisionGap Down Related Companies and Tools Related Companies Roivant Sciences Alternatives Revolution Medicines Alternatives Verona Pharma Alternatives BridgeBio Pharma Alternatives Elanco Animal Health Alternatives Grifols Alternatives Telix Pharmaceuticals Limited American Depositary Shares Alternatives TG Therapeutics Alternatives Nuvalent Alternatives Legend Biotech Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HRMY) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Harmony Biosciences Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Harmony Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HRMY Stock Free HRMY Stock Alerts